Related Experiment Video
Updated: Jun 13, 2025
06:51
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
12.5K
The 3 Ds: Depression, Dysbiosis, and Clostridiodes difficile
Antoine Boustany1, Paul Feuerstadt2,3, Glenn Tillotson4
1Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA.
Advances in Therapy
|September 14, 2024
Summary
This study examines the link between depression, gut dysbiosis, and Clostridioides difficile infections. It highlights how antidepressants may disrupt the gut microbiome, increasing infection risk and exploring new treatments.
Area of Science:
- Microbiology
- Neuroscience
- Gastroenterology
Background:
- Depression is a prevalent mental health disorder with complex causes, including microbiome factors.
- Antidepressant use is increasing, raising concerns about their impact on gut microbiome composition.
- Gut dysbiosis, an imbalance in gut bacteria, is linked to various health issues, including infections.
Purpose of the Study:
- To explore the relationship between depression, gut dysbiosis, and Clostridioides difficile infections (CDI).
- To investigate the effects of antidepressants on the gut microbiome and their potential contribution to dysbiosis and CDI.
- To discuss live biotherapeutic products as a novel treatment for recurrent CDI.
Main Methods:
- Literature review of studies on depression, gut microbiome, and Clostridioides difficile infections.
- Analysis of the antimicrobial properties of antidepressants and antipsychotics.
- Examination of the link between antidepressant use and CDI risk.
- Review of emerging research on live biotherapeutic products for recurrent CDI.
Main Results:
- Antidepressants and antipsychotics can exhibit antimicrobial activity, potentially altering the gut microbiome.
- Gut dysbiosis may increase susceptibility to opportunistic infections like Clostridioides difficile.
- Evidence suggests a correlation between antidepressant use and an elevated risk of developing CDI.
- Live biotherapeutic products show promise as a new therapeutic strategy for recurrent CDI.
Conclusions:
- The interplay between depression, gut dysbiosis, and CDI (the "3 Ds") is a significant health concern.
- Understanding the microbiome-modulating effects of psychotropic medications is crucial.
- Novel therapeutic approaches, such as live biotherapeutics, are needed for managing recurrent CDI.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
410
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
410
01:18Depression: Overview
227
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
227
01:17Irritable Bowel Syndrome I: Introduction
257
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
257
01:27Depressive Disorders: MDD and Dysthymia
69
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
69
01:30Inflammatory Bowel Disease II: Crohn's Disease
201
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
201
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
153
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
153